Comprasion of nifedipin versus magnesium salfate in Treatment of preterm labor

Phase 3

• Conditions: preterm labor.; Preterm labour and delivery

• Registration Number: IRCT201301281760N20
• Lead Sponsor: Vice Chancellor for Research and Technology, Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

24w-34w gestational age with a diagnosis of preterm labor; at least four contractions[During the 30 in 20 minutes with increasing cervical dilatation and effacement] (2cm dilatation or effacement of 80%).
Exclusion criteria: multiple pregnancies; corioamnionitis? preeclampsia, abruption previa, liver disease, heart and blood pressure, maternal vaginal bleeding; IUGR; IUFD; Fetal distress, fetal major anomaly; PPROM; (PR> 100, BP <90/50) ³ 5cm dilatation.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Premature birth control. Timepoint: Before 37 weeks of gestation. Method of measurement: Clinical.

Secondary Outcome Measures

Name	Time	Method
Adverse effects of maternal magnesium sulfate versus nifedipine. Timepoint: Three days a week during the first 48 hours of onset of pain. Method of measurement: clinical.;Magnesium sulfate versus nifedipine complication rate of fetal tachycardia. Timepoint: Three days a week during the first 48 hours of onset of pain. Method of measurement: clinical.;The effect of nifedipine versus magnesium sulfate to stop the contractions of. Timepoint: Three days a week during the first 48 hours of onset of pain. Method of measurement: Clinical.